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Background
Despite radical surgery, up to 33% of patients with rectal
cancer will develop locoregional relapse. The manage-
ment of these patients is particularly challenging. Surgery
is the mainstay of treatment for those with a mobile recur-
rence. However, the majority of patients develop recur-
rence involving the pelvic wall. In these patients,
multimodality therapy including radical surgery and
intraoperative radiotherapy have been reported with 5-
year survival of up to 31% and local control rates of 50–
71%. The most important factor for obtaining long-term
local control and survival is R0 resection. Extended sur-
gery such as abdomino-sacral resection has not been pop-
ular because of 5-year survival rates of 16–31%, and
significant postoperative morbidity. Re-recurrence follow-
ing surgery occurs locally and in the lung, and remains a
significant problem. In surgical treatment for local recur-
rence, surgeon-related factors are crucial. A staging system
using degree of fixation and other prognostic factors
should be developed so that appropriate treatment
modalities are applied to each case. Despite radical sur-
gery, up to 33% of patients with rectal cancer will develop
locoregional relapse. The management of these patients is
particularly challenging. Surgery is the mainstay of treat-
ment for those with a mobile recurrence. However, the
majority of patients develop recurrence involving the pel-
vic wall. In these patients, multimodality therapy includ-
ing radical surgery and intraoperative radiotherapy have
been reported with 5-year survival of up to 31% and local
control rates of 50–71%. The most important factor for
obtaining long-term local control and survival is R0 resec-
tion. Objective: To analyze the major complications after
exenteration of colo-rectal and canal anal malignancies.
Materials and methods
Fifty nine patients with colo-rectal and canal anal malig-
nancies underwent pelvic exenteration (PE) between
1984 and 2002. 48 patients underwent posterior pelvic
exenteration PPE, 8 total pelvic exenteration and 3 poste-
rior supraelevadora exenteration were performed.
Results
Major complications in the operative field involving the
urinary tract infection or the wound dehiscence occurred
in 29 patients (49.15%). The mortality rate was 3.3%.
Major complications often occurred in advanced primary
colorectal cancer affecting those with recurrent malignan-
cies.
Conclusion
PE is more beneficial to patients with colorectal and canal
anal cancer recurrence than to those with recurrent cancer.
Knowledge of the inherent complications and morbidity
of PE is essential.
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